Israel Fernandez-Pineda

Dr. Israel Fernandez-Pineda


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2016 in Journal of Cancer Survivorship
Verified
Journal Article
Closed access
PDF file
IFIsrael Fernandez-Pineda
Israel Fernandez-Pineda
MHM. M. Hudson
M. M. Hudson
APA. S. Pappo
A. S. Pappo
MBM. W. Bishop
M. W. Bishop
JKJ. L. Klosky
J. L. Klosky
KNK. K. Ness
K. K. Ness

1 January 2014 in World Journal of Hepatology
Verified
Journal Article
Closed access
IFIsrael Fernandez-Pineda
Israel Fernandez-Pineda
RCRosa Cabello-Laureano
Rosa Cabello-Laureano
During the first year of life, most of the liver neoplasms are benign in origin, but some of these histologically benign lesions may be challenging in their management. Although most hepatic hemangiomas can be safely observed until involution is documented, some patients will need treatment due to progressive hepatomegaly, hypothyroidism and/or cardiac failure. Large mesenchymal hamartomas may require extensive hepatic resection and an appropriate surgical plan is critical to obtain good results. For malignant neoplasms such as hepatoblastoma, complete surgical resection is the mainstay of curative therapy. The decision about whether to perform an upfront or delayed resection of a primary liver malignant tumor is based on many considerations, including the ease of resection, surgical expertise, tumor histology and stage, and the likely chemosensitivity of the tumor. This article reviews the initial management of the more common hepatic tumors of infancy, focusing on the differential diagnosis and treatment options.

23 September 2010 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
PDF file
IFIsrael Fernandez-Pineda
Israel Fernandez-Pineda
JLJuan Carlos Lopez-Gutierrez
Juan Carlos Lopez-Gutierrez
GVGema L Ramírez Villar
Gema L Ramírez Villar
CMCatalina Marquez
Catalina Marquez
MDMd
Md
Kasabach-Merritt phenomenon (KMP) is a serious coagulopathy with severe thrombocytopenia (<10,000/mm3) that occurs in the presence of an enlarging vascular tumor such as kaposiform hemangioendothelioma (KHE) and tufted angioma (TA). The natural history and treatment of these lesions remain controversial. The authors report a KHE case and a TA case that presented with KMP, describing their successful pharmacological management with vincristine, ticlopidine, and aspirin.

11 May 2018 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
IFIsrael Fernandez-Pineda
Israel Fernandez-Pineda
ADAndrew M. Davidoff
Andrew M. Davidoff
LLLu Lu
Lu Lu
BRBhaskar N. Rao
Bhaskar N. Rao
CWCarmen Wilson
Carmen Wilson
WCWassim Chemaitilly
Wassim Chemaitilly

1 January 2015 in World Journal of Hepatology
Verified
Journal Article
Open access
IFIsrael Fernandez-Pineda
Israel Fernandez-Pineda
The management of hepatic metastatic disease from solid tumors in adults has been extensively described and resection of metastatic liver lesions from colorectal adenocarcinoma, renal adenocarcinoma, breast cancer, testicular cancer, and neuroendocrine tumors (NET) have demonstrated therapeutic benefits in select patients. However, there are few reports in the literature on the management of hepatic metastatic disease in the pediatric and adolescent populations and the effectiveness of hepatic metastasectomy. This may be due to the much lower incidence of pediatric malignancies and the higher chemosensitivity of childhood tumors which make hepatic metastasectomy less likely to be required. We review liver involvement with metastatic disease from the main pediatric solid tumors, including neuroblastoma and Wilms tumor focusing on the management and treatment options. We also review other solid malignant tumors which may have liver metastases including germ cell tumors, gastrointestinal stromal tumors, osteosarcoma, desmoplastic small round cell tumors and NET. However, these histological subtypes are so rare in the pediatric and adolescent populations that the exact incidence and best management of hepatic metastatic disease are unknown and can only be extrapolated from adult series.

12 November 2016 in Pediatric Surgery International
Verified
Journal Article
Closed access
PDF file
DGD. F. Grabski
D. F. Grabski
APA. S. Pappo
A. S. Pappo
MKM. J. Krasin
M. J. Krasin
ADA. M. Davidoff
A. M. Davidoff
BRB. N. Rao
B. N. Rao
IFIsrael Fernandez-Pineda
Israel Fernandez-Pineda